Clinical Trial Update: A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cetuximab with cisplatin or carboplatin/pemetrexed as first-line therapy for malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Cancer | Phase 2 | Status: COMPLETED